Spain Reports Slight Decline in HIV Diagnoses, But Late Detection Remains a Concern
Table of Contents
- Spain Reports Slight Decline in HIV Diagnoses, But Late Detection Remains a Concern
- Strengthening Prevention and Worldwide Healthcare
- Shifting Demographics in Transmission
- Landmark Ruling: HIV-positive Individuals to Donate Organs
- Calls for “Zero Stigma” and Immediate Action
- Global Commitment Amidst Geopolitical Challenges
- Expanding Access to Prevention: PrEP and Long-Acting Injectables
Spain recorded 3,340 new HIV diagnoses in 2024, a slight decrease from 3,350 the previous year, but over half of these cases – 51.1% – were identified late, according to official data released this Monday.The figures, presented alongside the launch of the “Viva la HIVda 2025” campaign coinciding with World AIDS Day, underscore the ongoing challenges in early detection and prevention despite advancements in treatment and preventative measures.
Strengthening Prevention and Worldwide Healthcare
The Ministry of Health emphasizes the need to bolster prevention efforts, improve early diagnosis rates, and ensure access to treatment for all. “And, of course, continue guaranteeing the best tool we have, which is universal, free public healthcare, accessible to all people, wherever they come from,” the official affirmed.
Shifting Demographics in Transmission
epidemiological surveillance data reveals a shift in transmission patterns.While sexual transmission remains the primary mode of infection, transmission between men who have sex with men continues to be the most prevalent. Notably,for the first time,the number of individuals originating from countries outside of Spain now exceeds the number of Spanish-born individuals among new diagnoses. .
Landmark Ruling: HIV-positive Individuals to Donate Organs
In a significant advancement, Spain will repeal a 1987 regulation in 2025 allowing individuals living with HIV to donate organs to other HIV-positive recipients. “The repeal of this regulation is something necessary and very correct,” explained María Velasco, president of the AIDS Study Group (GeSIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. “It is something that came from a time when we had a lot of uncertainty…and thanks to antiretroviral treatment survival is similar to that of the general population.”
Calls for “Zero Stigma” and Immediate Action
The State Coordinator of HIV and AIDS (Cesida) has issued a manifesto demanding “zero stigma” for people living with HIV in all aspects of life – prisons, healthcare settings, schools, workplaces, and the media. “Success is not measured only in a suppressed viral load; is also measured in quality of life, emotional well-being and real possibility of a life project,” Cesida representatives stated. They also advocate for universal healthcare access and complete prevention strategies, including barrier-free PrEP, readily available post-exposure prophylaxis (PEP), self-testing options, and community-led campaigns. “For all of this to bring about change and have an impact…we cannot wait until 2030 and we need an immediate response.”
Global Commitment Amidst Geopolitical Challenges
The Minister of Health also expressed concern over global setbacks in HIV funding and governance,criticizing leaders who are reducing support for HIV response programs. Specifically,the minister accused certain figures,including Javier Milei,of undermining global health initiatives. The Ministry of Health remains committed to multilateralism and global health, notably as 2025 marks the mid-term evaluation of UNAIDS’ strategy to end the HIV epidemic as a public health threat by 2030. “We arrive at it at a time when scientific advances are absolutely extraordinary…But, still, we arrive in a complicated political context where we are seeing critically important and significant setbacks,” the official cautioned, reaffirming Spain’s unwavering support for the global effort.
Expanding Access to Prevention: PrEP and Long-Acting Injectables
The Spanish Ministry of Health is actively working to broaden access to preventative tools, including the incorporation of long-acting injectable PrEP into the public healthcare system. This aims to provide a more convenient and discreet option for individuals at high risk of HIV infection. Further initiatives include streamlining PrEP prescription processes and expanding awareness campaigns to reach vulnerable populations.
